BACKGROUND: Available medication for pain and joint stiffness release in osteoarthritis (OA) often gives considerable side effects. Undenatured type II collagen (UC-II) has been considered as a treatment for OA for its ability to prevent the progress of ...
Oentarini Tjandra +5 more
doaj +4 more sources
Undenatured collagen type II for the treatment of osteoarthritis: a review
<p class="abstract">Osteoarthritis is a prevalent musculoskeletal condition worldwide with rising rates in elderly people. Both mechanical and immunological factors are implicated in the pathogenesis of osteoarthritis resulting in destruction of the articular cartilage.
Ram Prabhoo, Gauri Billa
openaire +3 more sources
The authors would like to correct spelling mistakes (undenatured type II collagen) in the title, as well as in the main manuscript including the tables and figures in the title paper [...]
Rui Fan +9 more
doaj +2 more sources
Purpose Knee osteoarthritis (OA) is the most common form of clinical arthritis in middle‐aged and older individuals. Undenatured or native type II (TII) collagen derived from the chicken sternum has a good therapeutic effect on relieving severe pain of ...
Cheng Luo +3 more
doaj +2 more sources
Efficacy and tolerability of native (undenatured) type II collagen supplementation for joint health in healthy volunteers: a randomized double-blind placebo-controlled study [PDF]
Background In non-osteoarthritic individuals, the appearance of joint discomfort with physical activity is a potential indicator of initial joint degeneration. The present study aimed to evaluate the efficacy and tolerability of native (undenatured) type-
Ingrid Möller +5 more
doaj +2 more sources
Pain reduction and tolerance of type II undenatured collagen in patients with knee osteoarthritis
Background: Osteoarthritis (OA) is the most common cause of pain and disability in adults. Dietary supplements such as undenatured type II collagen (UC-II) have shown to have some benefits in OA treatment. This study aimed to assess changes in pain levels among knee OA patients treated with UC-II for 6 months.
Tomás F. Fernández-Jaén +7 more
openaire +3 more sources
The paper deals with an update on biologically active additives (BAAs) and emphasizes their role in normalizing and/or improving the functional status of organs and systems, including the gastrointestinal tract microflora, in reducing the risk of ...
I. S. Dydykina +4 more
doaj +3 more sources
Novel formulations ameliorate osteoarthritis in rats by inhibiting inflammation and oxidative stress. [PDF]
Treatments F1 (curcuminoids + gingerols + AKBA) to F4 (curcuminoids + AKBA) improved joint diameter, stride length, and paw area in OA rats. They significantly reduced MDA levels and increased antioxidant enzyme activities by lowering inflammatory markers such as IL‐1β, IL‐6, MMP‐8, TNF‐α, CRP, COMP, and LOX‐5, while increase the anti‐inflammatory ...
Erten F +7 more
europepmc +2 more sources
Modeling treatment of osteoarthritis with standard therapy and senolytic drugs. [PDF]
Osteoarthritis (OA), the most common form of joint disease, involves the progressive degradation of articular cartilage and is a major cause of chronic disability in aging populations.
Nourridine Siewe, Avner Friedman
doaj +2 more sources
Efficacy of oral nutrition supplementation enriched with hydroxymethylbutyrate (HMB) and undenatured type-II collagen (UC-II) combined with exercise training on osteoarthritis-related outcomes among adults with knee osteoarthritis in Klang Valley of Malaysia: study protocol for a randomised controlled trial [PDF]
Introduction Knee osteoarthritis (OA) is a serious public health problem since it is linked to loss of muscular function and independence, especially in older adults. In this study, the researchers have proposed a randomised controlled trial with a three-
Suzana Shahar +13 more
doaj +2 more sources

